The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: From a coarse to a fine dispersion

International Journal of Pharmaceutics

Volumn 368, Issue 1-2, 2009, Pages 193-198

  Driscoll, David F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Chapter <729>; Intralipid; Light obscuration; Light scattering; Mean droplet diameter; Percent fat > 5 m; United States Pharmacopeia

Indexed keywords

FAT; INTRALIPID; PLASTIC;

ARTICLE; DRUG FORMULATION; DRUG PACKAGING; DRUG QUALITY; EMULSION; MEASUREMENT; MEDICAL LITERATURE; PARTICLE SIZE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; DRUG PACKAGING; DRUG STABILITY; FAT EMULSIONS, INTRAVENOUS; HUMANS; PARENTERAL NUTRITION, TOTAL; PARTICLE SIZE; PHARMACOPOEIAS AS TOPIC; PLASTICS; REFERENCE STANDARDS; TIME FACTORS;

EID: 58949104751     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.059     Document Type: Article

References (37)

1. Baxter Communication, 2004. Announcement to Directors of Pharmacy, February 26. INTRALIPID IV Fat Emulsion Now Available in Plastic Containers. Baxter Healthcare Corporation.
2. Baxter Communication, 2007. Customer Letter, February 21, 2007. Globule Size Distribution of INTRALIPID I.V. Fat Emulsion-PFAT5 <0.05%. Baxter Nutrition Professional Services.
3. Bullock L., Fitzgerald J.F., and Walter W.V. Emulsion stability in total nutrient admixtures containing a pediatric amino acid formulation. J. Parenter. Enteral Nutr. 16 (1992) 64-68
4. Driscoll D.F. The significance of particle/globule sizing techniques in the safe use of intravenous lipid emulsions. J. Disp. Sci. Tech. 23 (2002) 679-687
5. Driscoll D.F. Examination of selection of light-scattering and light-obscuration acceptance criteria for lipid injectable emulsions. Pharmacoepial Forum 30 (2004) 2244-2253
6. Driscoll D.F. Lipid injectable emulsions. Nutr. Clin. Pract. 21 (2006) 381-386
7. Driscoll D.F. Lipid injectable emulsions: pharmacopeial and safety issues. Pharm. Res. 23 (2006) 1959-1969
8. Driscoll D.F. Profiles of the globule size distribution of 20% lipid injectable emulsions: a focus on packaging in plastic containers. Am. J. Health-Syst. Pharm. 64 (2007) 2032-2036
9. Driscoll D.F., and Bistrian B.R. The effects of packaging containers on the large-diameter tail of the globule size distribution (GSD) of lipid emulsions. Clin. Nutr. 24 (2005) P330
10. Driscoll D.F., Bhargava H.N., Li L., Zaim R.H., Babayan V.K., and Bistrian B.R. The physicochemical stability of total nutrient admixtures. Am. J. Health-Syst. Pharm. 52 (1995) 623-634
11. Driscoll D.F., Etzler F., Barber T.A., Nehne J., Niemann W., and Bistrian B.R. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int. J. Pharm. 219 (2001) 21-37
12. Driscoll D.F., Thoma A., Klu{combining double acute accent}tsch K., Bistrian B.R., and Nehne J. The effects of packaging and manufacturer on the large-diameter tail of the globule size distribution of lipid injectable emulsions-Part 2. Clin. Nutr. 24 (2005) 1126-1127 (LB028)
13. Driscoll D.F., Silvestri A.P., Mikrut B.A., and Bistrian B.R. Stability of adult-based total nutrient admixtures with soybean oil-based lipid injectable emulsions: the effect of glass versus plastic packaging. Am. J. Health-Syst. Pharm. 64 (2007) 396-403
14. Driscoll D.F., Ling P.R., and Bistrian B.R. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs. plastic product packaging. J. Parenter. Enteral Nutr. 31 (2007) 148-153
15. Driscoll, D.F., Thoma, A., Franke, R., Klütsch, K., Nehne, J., Bistrian, B.R. Fine vs. Coarse All-In-One (AIOs) as 3-chamber plastic (3-C-P) bags over 48 h. Am. J. Health-Syst. Pharm., in press.
16. Driscoll D.F., Ling P.R., Silvestri A.P., and Bistrian B.R. Fine vs. coarse total nutrient admixture infusions over 96 h in rats: fat globule size and hepatic function. J. Parenter. Enteral Nutr. 32 (2008) 294
17. Driscoll D.F., Bistrian B.R., Demmelmair H., and Koletzko B. Pharmaceutical and clinical aspects of lipid emulsions in neonatology. Clin. Nutr. 27 (2008) 497-503
18. Geyer R. Parenteral nutrition. Physiol. Rev. 40 (1960) 150-186
19. Globule Size Distribution in Intravenous Emulsions. Proposed pharmacopeial preview. Proposed . Pharmacopeial Forum 17 (1991) 2219-2222
20. Globule Size Distribution in Intravenous Emulsions. Proposed , in-process revision. Pharmacopeial Forum 20 (1994) 7170-7174
21. Globule Size Distribution in Intravenous Emulsions. Proposed , in-process revision. Pharmacopeial Forum 21 (1995) 1334-1340
22. Globule Size Distribution in Intravenous Emulsions. Proposed 〈Chapter 729〉, in-process revision. Pharmacopeial Forum 24 (1998) 6988-6994
23. Globule Size Distribution in Lipid Injectable Emulsions. Proposed 〈Chapter 729〉, pharmacopeial preview. Pharmacopeial Forum 24 (2004) 6988-6994
24. Globule Size Distribution in Lipid Injectable Emulsions. Proposed 〈Chapter 729〉, in-process revision. Pharmacopeial Forum 31 (2005) 1448-1453
25. Globule Size Distribution in Lipid Injectable Emulsions, 2007, June 1. 〈Chapter 729〉 United States Pharmacopeia, USP30-NF25, 2nd Supplement.
26. Globule Size Distribution in Lipid Injectable Emulsions. Chapter 〈729〉 The United States Pharmacopeia 31/National Formulary 26 vol. 1 (2008) pp. 285-287
27. Martin C.R., Dumas G.J., Zheng Z., MacKinnon B., Al-Aweel I., Bistrian B.R., Pursley D.M., and Driscoll D.F. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass vs. plastic containers: a retrospective analysis. J. Pediatr. 152 (2008) 232-236
28. Mehta R.C., Head L.F., Hazrati A.M., Parr M., Rapp R.P., and DeLuca P.P. Fat emulsion particle size distribution in total nutrient admixtures. Am. J. Hosp. Pharm. 49 (1992) 2749-2755
29. Particulate Matter in Injections. Chapter <788>, United States Pharmacopeia 23/National Formulary vol. 18 (1994) pp. 1813-1816
30. Sayeed F.A., Johnson H.W., Sukumaran K.B., Raihle J.A., Moule D.L., Stemlach H.A., and Majors K.R. Stability of Liposyn II fat emulsion in total nutrient admixtures. Am. J. Hosp. Pharm. 43 (1986) 1230-1235
31. Sayeed F.A., Tripp M.G., Sukumaran K.B., Mikrut B.A., Stelmach H.A., and Raihle J.A. Stability of total nutrient admixtures using various intravenous fat emulsions. Am. J. Hosp. Pharm. 44 (1987) 2271-2280
32. Sayeed F.A., Tripp M.G., Sukumaran K.B., Mikrut B.A., Stelmach H.A., and Raihle J.A. Stability of various total nutrient admixture formulations using Liposyn II and Aminosyn II. Am. J. Hosp. Pharm. 44 (1987) 2280-2286
33. Stare F.J. Harvard's Department of Nutrition, 1942-1986 (1987), The Christopher Publishing House, Norwell, MA
34. Tripp M.G., Menon S.K., and Mikrut B.A. Stability of total nutrient admixtures in a dual-chamber flexible container. Am. J. Hosp. Pharm. 47 (1990) 2496-2503
35. Vinnars E., and Wilmore D.W. History of parenteral nutrition. J. Parenter. Enteral Nutr. 27 (2003) 230-235
36. Wretlind A. Development of fat emulsions. J. Parenter. Enteral Nutr. 5 (1981) 230-235
37. Zaloga G.P., Dunham A.J., Gonyon T.M., Best L.M., and Groves M. Nutr. Clin. Pract. 22 (2007) 367-369 (Letter to the Editor)